切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2022, Vol. 08 ›› Issue (01) : 16 -22. doi: 10.3877/cma.j.issn.2096-1537.2022.01.002

临床研究

苯磺酸瑞马唑仑用于ICU机械通气患者镇静的有效性与安全性
詹维强1, 许明1, 李梦蝶1, 常林2, 芦乙滨1,()   
  1. 1. 464000 河南信阳,郑州大学附属信阳医院 信阳市中心医院重症医学科
    2. 443005 湖北宜昌,宜昌人福药业有限责任公司
  • 收稿日期:2021-08-12 出版日期:2022-02-28
  • 通信作者: 芦乙滨
  • 基金资助:
    中华国际医学交流基金(Z-2017-24-2028-37)

Efficacy and safety of Remimazolam in sedation of ICU patients with mechanical ventilation

Weiqiang Zhan1, Ming Xu1, Mengdie Li1, Lin Chang2, Yibin Lu1,()   

  1. 1. Department of Intensive Care Medicine, Xinyang Central Hospital, Xinyang Hospital Affiliated to Zhengzhou University, Xinyang 464000, China
    2. Yichang Humanwell Pharmaceutical Co., Ltd., Yichang 443005, China
  • Received:2021-08-12 Published:2022-02-28
  • Corresponding author: Yibin Lu
引用本文:

詹维强, 许明, 李梦蝶, 常林, 芦乙滨. 苯磺酸瑞马唑仑用于ICU机械通气患者镇静的有效性与安全性[J]. 中华重症医学电子杂志, 2022, 08(01): 16-22.

Weiqiang Zhan, Ming Xu, Mengdie Li, Lin Chang, Yibin Lu. Efficacy and safety of Remimazolam in sedation of ICU patients with mechanical ventilation[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2022, 08(01): 16-22.

目的

探讨苯磺酸瑞马唑仑对ICU机械通气患者镇静的有效性及对呼吸循环系统的影响。

方法

采用前瞻性随机对照研究方法,选择2021年1月至9月信阳市中心医院综合ICU收治的有镇静需求的机械通气患者92例,将其随机分为2组,苯磺酸瑞马唑仑组(R组)45例,丙泊酚组(P组)47例。2组患者分别给予舒芬太尼镇痛,维持镇痛目标为重症监护疼痛观察工具(CPOT)评分<2分。其中R组给予苯磺酸瑞马唑仑7 mg负荷剂量及2.5 mg追加剂量(达不到目标镇静深度时)静脉推注,再以0.1~0.5 mg/(kg·h)静脉泵入维持镇静;P组对于年龄<55岁的患者给予丙泊酚0.5~1.5 mg/kg负荷剂量静脉推注(年龄>55岁患者酌情减量),再以0.1~1 mg/(kg·h)静脉泵入维持镇静。根据Richmond镇静-躁动(RASS)评分标准,维持2组患者的目标镇静深度为-2~-3分。比较2组患者药物起效时间、停药后苏醒时间、用药前(T0)及用药后1 h(T1)、6 h(T6)、12 h(T12)、24 h(T24)时间点的心率(HR)、收缩压(SBP)、舒张压(DBP)、左室射血分数(LVEF)、左室流出道速度-时间积分(VTI)、呼吸频率(RR)、脉搏血氧饱和度(SpO2)的变化。

结果

2组患者性别、年龄、身高、体质量、急性生理学与慢性健康状况评分Ⅱ(APACHE Ⅱ)等基线资料、用药前呼吸及血流动力学指标等比较,差异均无统计学意义(P>0.05)。给药后R组和P组起效时间比较,差异无统计学意义[(85.7±18.6)s vs(94.7±32.6)s,P=0.108];停药后R组比P组苏醒时间更短,差异有统计意义[(22.6±6.25)s vs(25.9±7.9)s,P=0.028];组内比较,相比于T0时间点,T1、T6、T12、T24时2组的HR、SBP、DBP、RR、LVEF、VTI均有下降,而SpO2上升,差异均有统计学意义(P<0.01);组间比较,2组患者用药后HR(T1、T6、T24)、SBP(T1、T6、T12、T24)、DBP(T1、T6、T12)、LVEF(T1、T6、T24)、VTI(T1、T6、T24)比较,差异均有统计学意义(P<0.05),而RR(T1、T6、T12、T24)、SpO2(T1、T6、T12、T24)比较,差异无统计学意义(P>0.05)。

结论

苯磺酸瑞马唑仑、丙泊酚都具有起效快的优点。相比于丙泊酚,苯磺酸瑞马唑仑苏醒快且对于心率、血压、心脏收缩功能影响更小,更适合于ICU患者的镇静治疗。

Objective

To explore the sedative effect of Remimazolam on patients with mechanical ventilation in intensive care unit (ICU) and its influence on respiratory and circulatory system.

Methods

In a prospective randomized controlled study, ninety-two mechanical ventilated patients who needed sedation were enrolled in ICU of Xinyang Central Hospital from January 2021 to September 2021. The patients in two groups were given Sufentanil for analgesia, with critically-ill pain observation tool (CPOT) score less than 2 points, and were randomly divided into two groups, including 45 cases in Remimazolam group (group R) and 47 cases in Propofol group (group P). In group R, patients were received Remimazolam at a loading dose of 7 mg and an additional dose of 2.5 mg (when sedation target of RASS was not reached) by intravenous injection, and then a maintenance dose of 0.1-0.5 mg/(kg·h) by intravenous pump. In group P, patients younger than 55 years old were received Propofol at 0.5-1.5 mg/kg by intravenous injection (patients older than 55 years old were received at a reduced dose as appropriate) followed by a 0.1-1 mg/(kg·h) maintenance dose by intravenous pump. According to RASS sedation score, the target sedation depth of the two groups was maintained at -2- -3 points. The time to onset of effect of drugs and the wake-up time of the patients (after the withdrawal of the drug) were recorded and compared between the two groups. The changes of heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), left ventricular ejection fractions (LVEF), left ventricular outflow tract velocity time integral (VTI), respiratory rate (RR) and saturation of pulse oxygen (SpO2) were recorded and compared between the two groups before (T0) and at 1 h (T1), 6 h (T6), 12 h (T12) and 24 h (T24) after medication.

Results

We found no difference between baseline clinical data such as gender, age, height, weight, APACHE Ⅱ score and hemodynamic or respiratory parameters before treatment between the two groups. There was no significant difference of the time to onset of effect of drugs between group R and group P after treatment [(85.7±18.6) s vs (94.7±32.6) s, P=0.108]. After administration stopped, wake-up time of group R was shorter than that of group P [(22.6±6.25) s vs (25.9±7.9) s, P=0.028]. Compared with T0 time point, the mean values of HR, SBP, DBP, RR, LVEF and VTI recorded at T1, T6, T12 and T24 time points in the two groups all decreased, while the mean values of SpO2 increased. Intra-group analysis showed that there were statistically significant differences between the above parameters at each time point after administration and before administration (P<0.01). Inter-group analysis showed that there were statistically significant differences in mean values of HR(T1, T6, T24), SBP(T1, T6, T12, T24), DBP(T1, T6, T12), LVEF(T1, T6, T24) and VTI(T1, T6, T24) between the two groups (P<0.05),However, there was no significant difference in RR and SpO2 between two groups at T1-T24 time points (P>0.05).

Conclusions

Either Remimazolam or Propofol have the advantage of rapid onset. When compared with Propofol, patients who received Remimazolam are more easier to wake-up (after administration stopped) and has less influence on heart rate, blood pressure and cardiac systolic function, which is more suitable for sedation treatment of ICU patients.

表1 2组接受机械通气患者基线资料和临床特征比较
表2 2组接受机械通气患者起效及苏醒时间比较(s,
xˉ
±s
表3 2组接受机械通气患者镇静前后血流动力学、呼吸参数比较(
xˉ
±s
1
中华医学会重症医学分会. 中国成人ICU镇痛和镇静治疗指南[J/OL]. 中华重症医学电子杂志, 2018, 4(2): 90-113.
2
Iirola T, Aantaa R, Laitio R, et al. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients [J]. Crit Care, 2011, 15(5): 1-10.
3
Shehabi Y, Nakae H, Hammond N, et al. The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients [J]. Anaesth Intensive Care, 2010, 38(1): 82-90.
4
王晓东, 于明涛, 刘子强, 等. 苯磺酸瑞马唑仑联合艾司氯胺酮静脉麻醉在内镜下逆行胰胆管造影术中的临床应用 [J]. 中国医刊, 2021, 56(3): 274-277.
5
胡千华, 周文娟, 侯鸣宇, 等. 静脉注射苯磺酸瑞马唑仑在肥胖患者无痛胃肠镜检查中的应用分析 [J]. 药品评价, 2020, (24): 55-58.
6
Tate JA, Devito Dabbs A, Hoffman LA, et al. Anxiety and agitation in mechanically ventilated patients [J]. Qual Health Res, 2012, 22(2): 157-173.
7
Chanques G, Jaber S, Barbotte E, et al. Impact of systematic evaluation of pain and agitation in an intensive care unit [J]. Crit Care Med, 2006, 34(6): 1691-1699.
8
武继民, 马亚玲, 牛悦峰, 等. 国产丙泊酚用于全麻诱导的临床观察[J]. 临床麻醉学杂志, 2001, 17(6): 333.
9
陈琪, 李军. 丙泊酚的滥用与药物依赖性及其可能机制[J]. 中国药物依赖性杂志, 2019, 28(2): 96-99.
10
Möller Petrun A, Kamenik M. Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using Propofol or etomidate: a double-blind, randomized, clinical trial [J]. Br J Anaesth, 2013, 110(3): 388-396.
11
Zhou X, Li BX, Chen LM, et al. Etomidate plus Propofol versus Propofol alone for sedation during gastroscopy: a randomized prospective clinical trial [J]. Surg Endosc, 2016, 30(11): 5108-5116.
12
苗玉良, 张鸿飞, 时文珠. 异丙酚输注综合征[J]. 中国急救医学, 2006, 26(1): 53-55.
13
唐冰, 王俊科, 冯婉玉. 人肝脏微粒体中CYP2B6对异丙酚代谢的催化作用[J]. 中华麻醉学杂志, 2007, 27(5): 475-476.
14
黄世杰. 用于结肠镜操作的超短效镇静/麻醉药瑞马唑仑 [J]. 国际药学研究杂志, 2015, 42(3): 369.
15
胡千华, 周文娟, 侯鸣宇, 等. 静脉注射苯磺酸瑞马唑仑在肥胖患者无痛胃肠镜检查中的应用分析 [J]. 药品评价, 2020, 17(24): 55-58.
16
Riff DS, Winkle PJ, Schwartz HI, et al. S1419: A phase Ⅱa, randomized, controlled, double-blind, dose-finding study evaluating the safety and pharmacodynamics of CNS 7056 in patients undergoing diagnostic upper gi endoscopy [J]. Gastrointest Endosc, 2010, 71(5): 156-157.
17
陈瑜, 蔡姝, 朱晓刚, 等. 瑞马唑仑用于老年患者全麻诱导时的镇静效果 [J]. 中华麻醉学杂志, 2020, 40(8): 974-976.
18
余婉秋, 李禹琼, 朱圣姬, 等. 苯磺酸瑞马唑仑与丙泊酚用于无痛结肠镜检查的有效性及安全性的随机、单盲、平行对照研究 [J]. 贵州医药, 2020, 44(6): 846-849.
19
Hu K, Xiang Q, Wang Z, et al. Effects of vitamin D receptor, cytochrome P450 3A, and cytochrome P450 oxidoreductase genetic polymorphisms on the pharmacokinetics of Remimazolam in healthy Chinese volunteers [J]. Clin Pharmacol Drug Dev, 2021, 10(1): 22-29.
20
古安城, 许重远, 曹婉雯, 等. 丙泊酚注射液在中国成年人中的群体药代动力学研究 [J]. 中国临床药理学杂志, 2020, 36(2): 189-192.
21
Xia J, Xu H, Yang Z, et al. Genome-Wide Analysis of Carboxylesterases (COEs) in the Whitefly, Bemisia tabaci (Gennadius) [J]. Int J Mol Sci, 2019, 20(20): 4973.
22
Sato S, Doi M, Morita K, et al. Remimazolam a new ultra-short acting anesthetic shows similar efficacy and superior hemodynamic stability vs. Propofol in general surgery patients with TIVA: results of a randomized, noninferiority, phase Ⅱb/Ⅲ trial[C]//Poster session presented at: the ANESTHESIOLOGY 2015 annual meeting. 2015: 24-28.
23
Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C, et al. Prolonged sedation of critically ill patients with midazolam or Propofol: impact on weaning and costs [J]. Crit Care Med, 1997, 25(1): 33-40.
24
杜金广, 唐显玲, 王熙兵, 等. 异丙酚对人动脉平滑肌细胞膜大电导钙激活钾通道的影响 [J]. 中华麻醉学杂志, 2006, 26(1): 87-88.
25
Freeman J, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine, Propofol and steroids on pulmonary metastasis in a murine model of breast cancer surgery [J]. Cancers, 2019, 11(5): 613.
26
陈艳, 肖正伦. 不同浓度丙泊酚对危重患者镇静深度和血流动力学的影响[J]. 中华急诊医学杂志, 2006, 15(12): 1139-1141.
27
Kleiman RB, Darpo B, Thorn M, et al. Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous Remimazolam on cardiac repolarization [J]. Br J Clin Pharmaco, 2020, 86(8): 1600-1609.
28
Antonik LJ, Goldwater DR, Kilpatrick GJ, et al. A placebo-and midazolam-controlled phase Ⅰ single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of Remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics [J]. Anesth Analg, 2012, 115(2): 274-283.
29
Pambianco DJ, Borkett KM, Riff DS, et al. A phase Ⅱb study comparing the safety and efficacy of Remimazolam and midazolam in patients undergoing colonoscopy [J]. Gastrointest Endosc, 2016, 83(5): 984-992.
[1] 豆艺璇, 黄怀, 钱绮雯, 邢然然, 林丽, 白建芳. 低强度吸气肌训练对机械通气患者肺康复的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 370-375.
[2] 徐娟, 孙汝贤, 赵东亚, 张清艳, 金兆辰, 蔡燕. 右美托咪定序贯镇静模式对中深度镇静的机械通气患者预后和谵妄的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 363-369.
[3] 许振琦, 易伟, 范闻轩, 王金锋. 经鼻高流量氧疗与无创机械通气在严重创伤术后轻中度低氧血症患者中的临床应用[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 306-309.
[4] 周顺, 赵素侠, 时静静, 吴双双, 吴圆圆, 李金山. 丙泊酚-舒芬太尼复合七氟烷吸入对小儿腹腔镜疝囊高位结扎术的麻醉效果及安全性[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 603-607.
[5] 曾凯旋, 何国安. 丙泊酚与七氟烷在老年腹股沟疝腹腔镜手术的应用效果及安全性比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(03): 316-321.
[6] 李鑫, 高元丽, 经俊, 陆星, 马臻. 纳布啡复合丙泊酚在腹腔镜经腹腹膜前腹股沟疝修补术中的应用研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 191-195.
[7] 钱晓英, 吴新, 徐婷婷. 颅脑损伤并发呼吸衰竭患者早期机械通气的效果分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 526-528.
[8] 陈静, 张春明, 周斌, 吴明明. 甲苯磺酸瑞马唑仑联合瑞芬太尼全身麻醉对胸腔镜肺叶切除患者术后应激反应及血清PAF、γ干扰素的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 554-556.
[9] 代芬, 卞士柱. 无创机械通气联合肺康复在肺动脉高压呼吸衰竭治疗中的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 560-562.
[10] 程传丽, 曾慧, 周静, 孙凌霞, 吴敏, 钱明江, 陈武, 万洁, 周仁佳. 超声引导下胸肺物理治疗对机械通气患者膈肌功能的疗效分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 563-565.
[11] 徐欣轶, 薛蓓, 蒋莉, 陈慧. NRI联合CFS评分对肺癌术后机械通气的预测分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 358-360.
[12] 林金锋, 张素燕, 田李均, 曹志龙, 徐俊贤, 韩旭东. 短暂呼气末阻塞法用于指导机械通气患者撤机的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 266-268.
[13] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[14] 刘帅, 徐珊珊, 王淑雅, 侯梦雪, 苗明月, 田莹, 张琳琳, 周建新. 成人重症患者镇痛镇静诊疗流程[J]. 中华重症医学电子杂志, 2023, 09(02): 135-142.
[15] 喇宏玲, 李育耕, 阿里木江·司马义, 徐桂萍, 苏涛. 右美托咪定复合舒芬太尼应用于肥胖患者无痛胃镜检查清醒镇静的效果[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 77-81.
阅读次数
全文


摘要